Inter-hospital variation in resource utilization of diagnostic and follow-up biomarkers in adult community-acquired pneumonia

S. Vestjens (Nieuwegein, Netherlands)

Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Session: Discussion of vaccines, biomarkers and risk factors analysis  
Session type: Poster Discussion
Number: 4524
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Vestjens (Nieuwegein, Netherlands). Inter-hospital variation in resource utilization of diagnostic and follow-up biomarkers in adult community-acquired pneumonia. 4524

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A prediction rule to identify allocation of inpatient care in community-acquired pneumonia
Source: Eur Respir J 2003; 21: 695-701
Year: 2003



The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020




On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012

Determinants of performance of indicators on antibiotic use in community-acquired pneumonia (CAP) at hospitals
Source: Eur Respir J 2005; 26: Suppl. 49, 638s
Year: 2005

Seasonal variation in outcome for hospitalised patients with community-acquired pneumonia
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018


Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 992-993
Year: 2011


Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 991-992
Year: 2011


Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia?
Source: Eur Respir J, 50 (4) 1700307; 10.1183/13993003.00307-2017
Year: 2017



Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


The cost of inpatient care in community-acquired pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 258s
Year: 2005

Use of a specific risk prediction rule for the hospital management of patients with community-acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 546s
Year: 2003

Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Adult Malaysian patients with community-acquired pneumonia: comparing two severity scoring systems in predicting need for ventilation
Source: Eur Respir J 2007; 30: Suppl. 51, 677s
Year: 2007

Comparison of the predictive performance of severity assessment tools in community-acquired or health care-associated pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013


Implementation of ERS guidelines for the management of adult community-acquired pneumonia in a primary care hospital
Source: Eur Respir J 2001; 18: Suppl. 33, 503s
Year: 2001

The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


Value of routine microbial investigation in low-risk patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 420s
Year: 2002

Cost minimization for community-acquired pneumonia management in Belarussian hospital from implementation of clinical guidelines
Source: Eur Respir J 2005; 26: Suppl. 49, 258s
Year: 2005

Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect
Source: Eur Respir J 2012; 39: 7-8
Year: 2012